000 01188 a2200301 4500
005 20250514190156.0
264 0 _c20040625
008 200406s 0 0 eng d
022 _a0193-1849
024 7 _a10.1152/ajpendo.00014.2004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aD'Alessio, David A
245 0 0 _aGlucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
_h[electronic resource]
260 _bAmerican journal of physiology. Endocrinology and metabolism
_cJun 2004
300 _aE882-90 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aDiabetes Mellitus, Type 1
_xdrug therapy
650 0 4 _aGlucagon
_xphysiology
650 0 4 _aGlucagon-Like Peptide 1
650 0 4 _aHumans
650 0 4 _aInsulin
_xphysiology
650 0 4 _aPeptide Fragments
_xphysiology
650 0 4 _aProtein Precursors
_xphysiology
700 1 _aVahl, Torsten P
773 0 _tAmerican journal of physiology. Endocrinology and metabolism
_gvol. 286
_gno. 6
_gp. E882-90
856 4 0 _uhttps://doi.org/10.1152/ajpendo.00014.2004
_zAvailable from publisher's website
999 _c14850043
_d14850043